Stocks

Kohl's Corporation KSS is likely to register a top-line decline when it reports first-quarter fiscal 2025 earnings on May 29. The Zacks Consensus Estimate for quarterly revenues is pegged at $3.2 billion, which indicates a 5.2% decrease from the year-ago quarter’s reported figure. For …

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and industries. Another thing that can drive investing is the fear of missing out, …

The Responsible Rider Masterclass Water 101 Module, powered by BRP, is Now LiveSea-Doo is Encouraging All Riders to Prioritize Safety and Responsible Riding This Summer. (CNW Group/BRP Inc.) VALCOURT, QC, May 23, 2025 /CNW/ - As summer is right around the corner, Sea-Doo, iconic …

TORONTO, May 23, 2025 (GLOBE NEWSWIRE) -- Martinrea International Inc. (TSX: MRE) (“Martinrea” or the “Company”), today announced that it has filed with the Toronto Stock Exchange (the “TSX”), and the TSX has accepted, its notice of intention to make a normal course issuer …

SOUTH SAN FRANCISCO, Calif., May 23, 2025 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products for cancer and autoimmune disease, today announced that it will participate in four upcoming investor …

Positive CHMP opinion based on FELIX clinical trial of obecabtagene autoleucel (obe-cel) in adult patients with r/r B-ALL, demonstrating high and durable response rates and low toxicityOpinion follows FDA approval and MHRA conditional marketing authorisationEuropean Commission (EC) decision on conditional marketing authorization application (MAA) …

DuPont de Nemours, Inc. DD expanded its portfolio with the launch of AmberChrom TQ1 chromatography resin to purify oligonucleotides and peptides for a variety of biopharma applications. The chromatography resin will facilitate the rapid development and commercialization of oligonucleotide and peptide therapeutics. The new …